The University of Wisconsin School of Medicine and Public Health at UW–Madison and GE HealthCare announced today a 10-year strategic collaboration that builds on an iconic relationship spanning more than 40 years. The new research collaboration ex Combining UW–Madison’s world-class…
Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation of the OncoPrism immunotherapy predictive diagnostic assay, enabling physicians to use the test to help guide treatment decisions for patients with metastatic or recurrent squamous cell carcinoma…
BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development and Biomanufacturing Today BIOVECTRA celebrates the completion of its $90 million plus biologics expansion at the company’s new state-of-the-art Biomanufacturing Centre with project partners the Government of Canada and Government of…
ventureLAB concluded its 3rd annual HardTech Summit on November 8 & 9 in partnership with York Region, bringing together 800 global leaders, founders, partners, innovators, government officials and regulators both virtually and in person at Toronto Marriott Markham. Canada’s premier technology…
Aya Healthcare Acquires Winnow AI, a Data Science Driven Platform to Recruit Passive Physicians Aya Healthcare, the largest healthcare talent software and staffing company in the United States, today announced the acquisition of Winnow AI, a data science- driven solution…
Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation sequencing system. The platform offers a revolutionary leap toward rapid…
Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has successfully completed the world’s first-in-human case utilizing its newest donor lung preservation technology, the BAROguard™ Donor Lung Preservation System, which received FDA 510(k) clearance in August 2023.…
BioMimetix JV, LLC, a clinical-stage biotechnology company developing metalloporphyrins, a novel drug class for the treatment of cancer patients, today announced the presentation of encouraging data from its Phase 2 study of lead candidate, BMX-001, for the treatment of high-grade…
Lunovus Enhances Its Eyecare Software and Service Solutions with Acquisition of Diamond Studios Lunovus LLC, a physician-owned pioneer in the eyecare industry, known for its advanced medical software and eye care supplementation solutions, has officially acquired Diamond Studios, a distinguished…
Global Artificial Intelligence in Healthcare Research Report 2023 – ResearchAndMarkets.com The “Global Market for Artificial Intelligence in Healthcare 2023” report has been added to ResearchAndMarkets.com’s offering. As of 2021, the market is estimated to be valued at approximately USD 6.1 billion, with a projected…
Genome Insight to Unveil Hong Kong Real-World Evidence on Target Enhanced Whole Genome Sequencing at 2023 AACR-KCA Joint Conference Genome Insight, a precision healthcare solutions company advancing whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease,…
Avistone Announces the First Approval of Vebreltinib for MET Exon 14 Skipping Non-Small Cell Lung Cancer Opening a New Chapter in MET-targeted Treatment of Lung Cancer Avistone Biotechnology Co. Ltd. (“Avistone” or “the Company”), an innovative biotechnology company focused on…